People with severe but stable ischemic heart disease don’t benefit any more from invasive CV procedures than they do from optimal medical therapy and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.

A “CTA-for-All” stroke imaging policy improved LVO detection, fast-tracked intervention and improved outcomes in a recent study of patients with acute ischemic stroke, researchers reported in Stroke.

California-based tech company HeartVista announced Oct. 29 it had received FDA clearance for its AI-assisted One Click cardiac MRI acquisition software.

Urine flow rate-guided hydration, as opposed to left ventricular end-diastolic pressure-guided hydration, could prevent more complications in CKD patients who are at a high risk for contrast-induced kidney injury.

Researchers have developed a point-of-care smartphone app that helps physicians ID cardiac implanted electrical devices in urgent or emergent settings, according to a study published in JACC: Clinical Electrophysiology.

A shortened, three-month course of dual antiplatelet therapy might be a safer bet than 12-month treatment for patients at a high risk of bleeding after PCI and implantation of a drug-eluting stent.

Five-year results of the ABSORB III trial suggest that, while target lesion failure and scaffold thrombosis have remained apparent in patients implanted with bioresorbable vascular scaffolds, the poor outcomes associated with BVS seemed to subside after three years, when the stents had completely dissolved.

Leveraging machine learning to read cardiac MRIs could speed up scan analysis while retaining the same accuracy as a physician, researchers reported this month.